These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 912965

  • 21. Comparison of metrizamide and iohexol for cisternal myelographic examination of dogs.
    Puglisi TA, Green RW, Hall CL, Read WK, Green RA, Tangner CH, Mann FA, Hobson HP.
    Am J Vet Res; 1986 Aug; 47(8):1863-9. PubMed ID: 3530068
    [Abstract] [Full Text] [Related]

  • 22. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD, Bach-Gansmo T, Dahlstrom K.
    Invest Radiol; 1985 Aug; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [Abstract] [Full Text] [Related]

  • 23. [Side effects of 2 water-soluble contrast media used in myelography].
    Caillé JM.
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
    [No Abstract] [Full Text] [Related]

  • 24. Relationship between contrast medium dose and adverse effects in lumbar myelography.
    Wilmink JT, Lindeboom SF, Vencken LM, vd Burg W.
    Diagn Imaging Clin Med; 1984 Dec; 53(4):208-14. PubMed ID: 6380885
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. MR characteristics of iophendylate (Pantopaque).
    Hackney DB, Grossman RI, Zimmerman RA, Joseph PM, Goldberg HI, Bilaniuk LT.
    J Comput Assist Tomogr; 1986 Dec; 10(3):401-3. PubMed ID: 3486195
    [Abstract] [Full Text] [Related]

  • 27. [Complications following myelography with positive contrast media (Pantopaque, Amipaque). Pathomorphologic findings in 2 fatal cases].
    Baessler B, Lahl R.
    Zentralbl Neurochir; 1985 Dec; 46(2):141-50. PubMed ID: 4060930
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and morbidity of water soluble and oil-based myelography. Study compares both methods in 314 patients.
    Dombrowski ET, Rezaian SM, Northcutt C, Boyd W, Fundell L, Anderson C, Malesky E.
    Orthop Rev; 1986 Jan; 15(1):24-9. PubMed ID: 3453436
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States.
    Goldstein HA, Pfennig D.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Jan; 128():167-70. PubMed ID: 2568788
    [Abstract] [Full Text] [Related]

  • 32. Lumbar myelography: contrast agents used in the past, present, and future.
    Valenti RM.
    Radiol Technol; 1987 Jan; 58(6):493-6. PubMed ID: 3615840
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Metrizamide for myelography.
    Handler LC.
    S Afr Med J; 1980 Feb 09; 57(6):185-6. PubMed ID: 7361206
    [No Abstract] [Full Text] [Related]

  • 38. Adverse side effects of metrizamide in myelography.
    Gelmers HJ.
    Neuroradiology; 1979 Sep 26; 18(3):119-23. PubMed ID: 492514
    [Abstract] [Full Text] [Related]

  • 39. Minimyelogram in cervical spinal cord trauma.
    Carol M, Ducker TB, Byrnes DP.
    Neurosurgery; 1980 Sep 26; 7(3):219-24. PubMed ID: 7207738
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.